These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4159354)

  • 1. [2 years of use of synthetic heparinoids in the treatment of cerebral thrombosis].
    Girard V; Picard P; Lefebvre P
    Gaz Med Fr; 1966 Feb; 73(3):581-4. PubMed ID: 4159354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of thrombosis by a synthetic heparinoid: indications in the obstetrical field].
    Baron F; Jahier J; Leclerc F; Chatelain P; Pelikan P; Gauliard M
    Lyon Med; 1969 Sep; 222(31):239-42 passim. PubMed ID: 4098609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic treatment of cerebral thromboembolism].
    Castellano F; Ambrosio A; Profeta G
    Neurochirurgie; 1970; 16(1):81-8. PubMed ID: 5446716
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of an antithrombotic enzyme of Agkistrodon halys venom in the treatment of cerebral thrombosis--report of 322 cases].
    Hao WX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):223-5. PubMed ID: 6536453
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study on the effect of 20% mannitol in treating cerebral thrombosis].
    Zhao PX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Jun; 20(3):169-72. PubMed ID: 3115734
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of xanthinol nicotinate ("complamin") in Nigerians with cerebral thrombosis.
    Dada TO
    West Afr Med J Niger Pract; 1971 Feb; 20(1):202-5. PubMed ID: 4930360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial of a synthetic heparinoid in the treatment of atherogenic dyslipemia].
    Broustet P; Dallocchio M; Crockett R; Bricaud H
    Gaz Med Fr; 1965 Oct; 72(20):3513-7. PubMed ID: 4159547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebral vessels and thrombosis].
    Miyakawa T; Sakuragawa N
    Rinsho Ketsueki; 1984 Jul; 25(7):1018-26. PubMed ID: 6502954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic combination of fibrinolytics and vasodilators in cerebral thrombosis].
    Puleo F
    G Gerontol; 1969 Dec; 17(12):1173-8. PubMed ID: 5403490
    [No Abstract]   [Full Text] [Related]  

  • 10. [The change in the nailfold microcirculation in patients with acute cerebral thrombosis treated with ligustrazine].
    Wang GJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Apr; 17(2):121-4. PubMed ID: 6478937
    [No Abstract]   [Full Text] [Related]  

  • 11. [Attempt at an aimed postoperative thrombosis prevention using a heparinoid derivative (SP 54)].
    Brehm R; Janisch H
    Wien Med Wochenschr; 1967 Aug; 117(32):757-63. PubMed ID: 4172513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydrocortisone in combined therapy of cerebral insults].
    Litvhchenko FI
    Vrach Delo; 1969 Aug; 8():155. PubMed ID: 5382476
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transformation of an ischemic infarction into a hemorrhagic one by anticoagulant treatment in a patient with cerebral embolism].
    Matías-Guiu J; Buenaventura I; Boada M; Dávalos A; Codina Puiggros A
    Med Clin (Barc); 1983 Oct; 81(13):598. PubMed ID: 6656391
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical analysis of 7 patients with cerebral venous thrombosis].
    Arboix A; Massons J; Oliveres M; Targa C
    Med Clin (Barc); 1996 Apr; 106(15):597. PubMed ID: 8656761
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of retinal venous thrombosis with an association of SP54 (Fibrase) and diisopropylammonium dichloroethanoate (Diedi)].
    Cantadori E; Canova R
    Minerva Oftalmol; 1969; 11(4):126-32. PubMed ID: 4190663
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolysin-anticoagulant therapy of cerebral thromboses].
    Lunev DK; Shmyrev VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(8):1121-8. PubMed ID: 4263309
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of certain nonvasoactive nucleosides (cytidine and uridine) in the treatment of cerebrovascular diseases.
    Sanguineti I; Zerbi D
    Panminerva Med; 1968 Mar; 10(3):81-92. PubMed ID: 5650178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical effects, therapeutic indications and posology of synthetic heparinoid 8.061 CB].
    Bourgeois S; Noel B
    Phlebologie; 1967; 20(3):321-8. PubMed ID: 4168153
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P; Caron JC
    Lille Med; 1971 Apr; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.